COHR

Business Context and Reporting Period

Company: II-VI Incorporated (filing as COHERENT CORP. in metadata, but text confirms II-VI)

Reporting Period: Fiscal year ended June 30, 2006

Business Overview: II-VI develops, manufactures, and markets high-technology materials and precision components for industrial, medical, military, security, and aerospace applications. Key product lines include infrared and near-infrared optical components, military infrared products, thermoelectric cooling/power generation, x-ray/gamma-ray sensors, and silicon carbide substrates. The company operates globally with significant manufacturing in the U.S., Singapore, China, and Vietnam.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Revenues increased 20% to $232.5 million, driven by a 19% increase in the Infrared Optics segment and the inclusion of a full year of results from the Marlow Industries acquisition (acquired Dec 2004).
• Earnings Decline: Net earnings dropped 54% to $10.8 million. This was primarily due to a non-cash goodwill impairment charge of $17.6 million recorded in the Military Infrared Optics segment (Exotic Electro-Optics).
• Bookings Surge: Bookings rose 29% to $242.3 million, indicating strong future demand across all segments, particularly in defense (UV filters) and industrial laser optics.
• Debt Reduction: Total debt decreased by approximately $13.8 million as the company paid down obligations related to the Marlow acquisition.
• Margin Compression: Gross margin percentage declined from 43% to 41% due to the lower-margin mix of Marlow products, increased raw material costs (selenium), and lower production yields in the military segment.

Guidance, Outlook, and Risks

Outlook and Guidance

Management projects fiscal 2007 revenues to range between $261 million and $267 million. Diluted earnings per share are projected to range from $1.08 to $1.17. The company anticipates continued strengthening in addressable markets.

Management Commentary

Management highlighted double-digit booking increases across all segments. The Infrared Optics segment benefited from the expanding global base of laser systems. The Compound Semiconductor Group (including Marlow) saw significant growth in medical and defense markets. The company is expanding capacity in Pennsylvania, Singapore, and China to meet demand.

Risks and Contingencies

• Internal Control Material Weakness: The company identified a material weakness in internal controls related to the lack of internal expertise in evaluating goodwill impairment testing. This resulted in the $17.6 million impairment charge and an adverse opinion on internal controls from auditors.
• Supply Chain Concentration: The company relies on limited sources for critical raw materials like Zinc Selenide (ZnSe) and Hydrogen Selenide. A failure of suppliers could materially impact operations.
• Government Dependence: A significant portion of revenue comes from defense contracts, which are subject to funding approvals and potential termination.
• Foreign Operations: Approximately 41% of revenues are from international sales, exposing the company to currency fluctuations (particularly the Japanese Yen) and geopolitical risks.

Investor Verification Checklist

• Goodwill Impairment: Verify the assumptions used in the $17.6 million impairment charge for the Military Infrared Optics segment and the remediation plan for the internal control weakness.
• Raw Material Costs: Monitor the impact of rising selenium and other raw material costs on future gross margins.
• Marlow Integration: Assess the full-year contribution of Marlow Industries to cash flow and profitability, noting its lower historical gross margins compared to core II-VI segments.
• Defense Contract Stability: Review the status of key military programs (e.g., Joint Strike Fighter, Apache targeting systems) given the reliance on government funding.
• Stock Repurchases: Track the execution of the $500,000 share repurchase program, of which 294,100 shares had been purchased as of June 30, 2006.